Viewing Study NCT01447394


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2025-12-30 @ 9:09 AM
Study NCT ID: NCT01447394
Status: WITHDRAWN
Last Update Posted: 2012-02-03
First Post: 2011-10-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module